I had the cash for my cat's $5,000 surgery. Should I have split the payment anyway?

Four years ago my cat needed emergency surgery. The estimate at the clinic was about $5,000. I had $5,000 in an emergency fund at Desjardins, set aside for this kind of moment. The cost wasn't the question. The cat's life was the question, and the answer was an easy yes.

At the front desk after the consent forms, the technician offered two payment options. Pay in full today, or apply for a Fairstone plan and split the bill into 4 equal monthly payments of $1,250 at 0%. I picked the Fairstone plan.

I had the $5,000 in the Desjardins account. The split was a choice, not a necessity. This post is about why I made that choice, who pays for the 0% offer when you take it, and what the regulator-led research says about whether Buy Now, Pay Later style point-of-sale financing is, on average, helping consumers or hurting them. The vet bill is the running example because emergency veterinary expenses are one of the cleanest cases where this kind of financing gets pitched, and one of the easiest to think about clearly.

What BNPL is, and the two products inside one app

BNPL, Buy Now Pay Later, is the family of point-of-sale financing products that have largely replaced layaway and store-card financing in Canadian and US checkouts since 2018. The Canadian brands you'll see most often are Affirm (which absorbed Canada's PayBright in 2020), Klarna, Afterpay, Sezzle, Scratchpay in the vet-specific corner, and Fairstone, the largest Canadian non-bank consumer lender, which sits at the longer-term-installment end of the same family.

There are two products in the family. Conflating them is where most of the confusion starts.

• Pay-in-4 (or pay-in-N). The purchase is split into 4 equal payments over six weeks at 0%, with instant soft-check approval. This is the product the marketing pitches. The only out-of-pocket cost is a late fee if a payment misses.
• Longer-term installment loans. Same checkout flow, different product. The same $5,000 vet bill stretched over 12, 24, or 36 months charges interest, sometimes 0% on a deferred-interest promo, more often 9.99% to 36.99% APR. This is a regular consumer loan dressed up in the BNPL UI.

These two look identical at the tablet on the counter. The difference lives in the term sheet, and it's worth slowing down to read it before tapping.

Vet financing in Canada, and the deferred-interest trap

Vet care is one of the segments point-of-sale lenders have leaned into hardest. The reasons are obvious from the lender's side. Bills are large (the average emergency surgery in Canada runs $2,000 to $8,000), often unbudgeted, emotionally weighted, and time-pressured. The buyer is rarely in a state to compare term sheets.

In Canada, three providers cover most of what you'll see at a vet clinic counter. Scratchpay handles the shorter-term, lower-friction end. Their "Take 5" plan is five payments over a few months at 0%. Fairstone, the lender I was actually offered at my clinic, handles the longer-term end. Their typical promo at point-of-sale is 6, 12, or 24 equal monthly payments at 0%, structured as a closed-end installment loan rather than a pay-in-4. Affirm covers the middle, with terms from three months to three years.

In the US, the big name in the same space is CareCredit, a Synchrony Bank product. CareCredit dominates the vet and medical financing market with deferred-interest promotional plans, typically "no interest if paid in full within 6, 12, or 18 months." CareCredit isn't available in Canada, but the deferred-interest structure shows up in Canadian promos from Fairstone and others too, and it's worth understanding because it's the product where the most consumer harm happens.

Here's how deferred interest works in the version most people don't catch. The lender accrues interest from day 0 at the full APR (commonly 29.99% on Fairstone promo plans). If you pay the balance in full before the promo ends, the accrued interest is waived. If you have even $1 left at the end of the promo, you owe all of the accrued interest, retroactive to day 0, on the original principal. On a $5,000 vet bill on a 12-month Fairstone-style 0% promo at 29.99%, finishing a month late means owing the lender roughly $1,500 in retroactive interest on top of the principal. The CFPB has written about this category extensively. It's the single biggest source of "I thought it was 0%" complaints in their database.

Whether the Fairstone plan I was offered was strictly deferred-interest or a true 0% promotional loan (some are; some aren't) is buried in the term sheet you sign at the clinic. I never read mine. That's the more honest answer about why I paid in full, and we'll come back to it.

The math on splitting a $5,000 vet bill at 0% over 4 months

The Fairstone plan I took was 4 monthly payments of $1,250 at 0%:

• Day 30: $1,250 charged to my chequing
• Day 60: $1,250
• Day 90: $1,250
• Day 120: $1,250

Total paid: $5,000. Interest paid: $0, every payment cleared on time.

What I was doing was leaving more money in my Desjardins emergency fund for longer. Over the 4 months, the outstanding balance declined linearly from $5,000 to $0, so the average amount kept in the savings account was roughly $2,500. At Desjardins's high-interest savings rate of around 2.5%, four months on $2,500 is about $21 of pre-tax interest income captured by splitting. Not transformative. (At one of the online challenger banks paying closer to 4%, the same setup would have been about $33.)

The split was a small positive on the math. About $21 of free liquidity, with two real downsides. Four monthly debits to track, and a non-trivial risk that the plan was deferred-interest rather than genuinely 0%. The reason I went ahead is in the four conditions I'll cover below. The more interesting question comes before "should I split". If the product is free for me, who's paying?

Where the money actually comes from

A four-month free loan to me has costs. Someone covers them. Working through the business model of point-of-sale financing in order of revenue magnitude:

1. The merchant pays the largest share

The single biggest revenue stream for a point-of-sale lender is the merchant discount rate, or MDR. It's the cut they take from the merchant on every financed transaction. The MDR for 0% promotional plans in North America runs roughly 3 to 6% of the order value, depending on volume, provider, and term length. For comparison, Visa and Mastercard interchange plus processing fees on a credit card purchase typically run 1.5 to 2.5%. From the merchant's side, this kind of financing is two to three times as expensive as accepting a credit card.

On a $5,000 vet bill at a 5% MDR, the clinic pays the lender about $250 to take the order. The buyer pays nothing extra. That $250 is the funding for the consumer's 0% loan, paid by the clinic, not by the customer.

Why does the clinic agree to a 5% fee? Two reasons, both supported by published BNPL operator data (Klarna and Afterpay both publish quarterly investor decks).

• Higher treatment-plan acceptance. When a customer is presented with a $5,000 surprise bill and the only option is pay in full, a non-trivial fraction walk out. Often they choose a less aggressive treatment plan, or in worst cases decline care. Adding a "12 payments of $416" option reportedly lifts treatment-plan acceptance in the high-ticket vet segment by a meaningful margin. The clinic earns more revenue net of the financing fee.
• Higher average treatment value. Once the bill is split, customers are more willing to accept the recommended treatment plan rather than the cost-trimmed alternative. The same anchoring effect that makes "$416 monthly" feel smaller than "$5,000 today" works in the clinic's favour.

The clinic trades roughly 5% in fees for materially higher revenue and better case acceptance. That's why the Fairstone or Affirm option is offered before you've even sat down with the vet.

2. Late-paying customers pay the second share

Most point-of-sale lenders charge a late fee when a scheduled payment misses. On Fairstone installment loans, missing a payment also triggers interest accrual at the full APR (around 29.99%) from that point forward, ending the 0% promo. Klarna's Canadian late fee is typically $7 per missed payment. Afterpay's is capped at the lesser of $10 or 25% of the order value. Scratchpay's varies by product.

The fee looks small. The economic cost is larger. On a 12-month Fairstone plan, missing a single payment late in the term can flip the entire remaining balance from 0% to ~30% APR. On the shorter pay-in-4 products, a $7 fee on a $1,250 payment a single day late is an effective annualised rate well over 100% for the period of lateness. The math of point-of-sale-financing late penalties is closer to payday loan economics than to credit card economics.

Crucially, the regulatory research finds that the customers who incur these fees are systematically the customers least able to absorb them. The free product for buyers like me, who have the cash and trust the auto-debit, is partly funded by penalties on financially stretched buyers who don't.

3. The longer-term interest product pays the third share

The same lenders that offer 0% promos also offer 6, 12, 24, and 36-month interest-bearing plans for larger purchases. The APR on these is real, typically 9.99% to 36.99% in Canada, with the lender's margin coming from a combination of the APR and any merchant subsidy. Deferred-interest promos sit in this segment too: 0% if you finish in time, otherwise full retroactive interest.

Affirm's public filings show interest income from this segment is roughly the same order of magnitude as merchant-fee income from the 0% segment. Fairstone, as a non-bank consumer lender, earns the majority of its revenue from interest on installment loans rather than from merchant fees. The 0% offer is a customer acquisition funnel. The long-term loan is where many cohorts ultimately monetise.

4. Data, card products, and float

Two smaller but growing revenue streams. Lenders that issue a physical or virtual card (Klarna Card, Affirm Card, Fairstone Select Mastercard) earn interchange on every swipe. And the aggregated transaction data, knowing what tens of millions of high-intent shoppers buy and when, is itself a monetisable asset, surfaced as targeted in-app promotions.

The float (the gap between when the lender pays the merchant on day 0 minus the MDR, and when they collect the monthly payments over the term) is small at current short-term rates but real, and grows with longer terms.

What the research shows about consumer outcomes

This is the section that should change how you feel about the radio button. The "0% interest" framing is honest at the product level and incomplete at the consumer-outcome level. There are now several years of regulator-led and peer-reviewed studies converging on the same picture.

CFPB 2022, market structure and delinquency

The US Consumer Financial Protection Bureau's 2022 report on the BNPL market covered five providers representing the bulk of US pay-in-4 volume. Three findings worth carrying into your decision:

• Approval rates in 2021 were roughly 73%, up from about 69% the year before. Substantially higher than credit card approval rates over the same period.
• The share of loans with a late fee charged grew from 7.8% in 2020 to 10.5% in 2021.
• Charge-off rates (loans the lender writes off as uncollectible) ran 2.4% in 2020 and 3.8% in 2021, higher than typical credit card portfolios.

The CFPB's framing in that report was, in their words, that BNPL operates in a "regulatory gray zone" and that the loose underwriting plus rising delinquency was an early-warning sign of stress in the borrower base.

CFPB 2023, the borrower profile

A follow-up CFPB report in March 2023, drawing on the Making Ends Meet Survey, profiled BNPL borrowers directly. The findings were not flattering for the "interest-free is harmless" reading.

• BNPL borrowers were more likely than non-borrowers to have used credit card cash advances, taken pawn loans, or overdrafted their bank accounts in the prior year.
• They were more likely to have a delinquent line of credit and more likely to be highly indebted relative to income.
• BNPL borrowers had lower average credit scores than non-borrowers and were disproportionately younger and lower-income.

The CFPB's reading: BNPL is disproportionately used by financially stressed consumers, not by the well-off "free-loan optimisers" the product is often marketed as serving. The buyer with $5,000 in an emergency fund staring at the Fairstone button is not the typical case.

UK FCA Woolard Review (2021)

In the UK, the Woolard Review of the unsecured credit market, commissioned by the Financial Conduct Authority and published in February 2021, concluded that BNPL posed a "significant potential consumer harm" and recommended bringing it under FCA regulation. The review noted that BNPL borrowers in the UK were materially more likely than the average adult to be in arrears on other credit products at the time of survey.

ASIC Australia, Report 672

Australia's regulator surveyed the BNPL market earlier and more bluntly. ASIC's 2020 Report 672, "Buy now pay later: An industry update", found that 21% of BNPL users surveyed had missed other household payments, such as rent, bills, or mortgage, in order to make a BNPL payment on time. About 20% of users had cut back on essentials such as groceries or medication to keep up with BNPL obligations.

That's not a statistic about the tail of stressed users. It's one in five, in a survey of typical BNPL users.

The convergence

The studies vary in geography, sample, and methodology, but the direction is consistent.

• For higher-income, financially-disciplined users, someone with a fully-funded emergency fund staring at a 0% offer on a non-discretionary expense, the split is approximately a free liquidity tool. The small positive effect the marketing claims is real for this segment.
• For the median user, who is disproportionately younger, lower-income, and credit-constrained, BNPL and similar point-of-sale financing is associated with measurably worse financial outcomes. Higher overdraft incidence, higher overall spending, higher delinquency on other credit products, and a higher likelihood of missing essential expenses to keep the payment schedule current.

That's not the same as saying point-of-sale financing is uniformly bad. It is saying that the population the product actually reaches is not the population the marketing assumes, and the net-of-everyone effect on consumer welfare is, at best, mixed and at worst negative.

When taking the split is the right call (my case)

The cleanest cases for taking the offer:

• You'd make this purchase at full price today if the financing didn't exist. Emergency vet surgery is the textbook example. Non-discretionary, time-pressured, you've already decided.
• You have the full balance set aside in an interest-bearing account. The split is purely a cash-flow optimisation. Four months of yield on the declining balance at 2.5 to 4% APY is $20 to $35 pre-tax. Twelve months at the same rates would be $60 to $100. Real, but not transformative.
• Your auto-debit setup is reliable across the full term. Card not expiring before the last payment, account well-funded, no history of bank-side fraud blocks. The late-payment math is unforgiving, especially on Fairstone plans where a missed payment can flip the 0% promo into ~30% APR for the rest of the term.
• The product is a genuine 0% promo, not deferred interest. If the offer says "no interest if paid in 12 months," read the term sheet for retroactive-interest language before signing.

When taking the split is the wrong tool

The cases where the same offer is dangerous:

• You don't have the full balance. The split is now a debt instrument, not a liquidity tool. Whether you can service the monthly payments without missing other bills is the real question, and it's the one ASIC's 21% statistic is about.
• You're stacking multiple point-of-sale plans. A $5,000 vet bill split into 12, plus a $1,200 phone split into 12, plus a $600 winter tire purchase split into 12, is a $650 monthly outflow for a full year. The monthly framing makes each one feel manageable. The cumulative is what the household ledger has to absorb.
• The "split" being offered is deferred-interest. The most common misclick on longer-term plans. Read the term sheet.

If the cash isn't there and the surgery can't wait

This is the case I want to spend more time on, because it's the one most readers are actually in. The estimate is $5,000, the surgery has to happen this week, and the dedicated reserve doesn't exist yet. In rough order of what to try first, cheapest and least binding to most expensive:

1. Ask the clinic about an in-house payment plan before you accept the Fairstone tablet. Many Canadian vet clinics will quietly arrange a 2 to 6 month interest-free split directly, especially for existing clients or for cases above $2,000. They prefer collecting from you in installments over selling the debt to a third party that takes 5%. The Fairstone offer is usually presented because it's the path of least resistance for the technician, not because the clinic has nothing else. Ask.

1. Have a frank conversation with the vet about treatment-plan tiers. Most $5,000 estimates contain a "must do" core and a "would be nice" margin. Extra imaging, premium pain management, extended monitoring, an overnight that could be a same-day discharge. A direct "what's the difference between the $5,000 plan and a $3,000 plan, and what does my cat lose?" question is rarely rude and often saves real money. Vets do this conversation routinely with owners and don't take offence.

1. Check Canadian veterinary financial assistance programs. The Farley Foundation helps low-income seniors and people on disability pay for veterinary care for their pets. Provincial SPCAs (BC SPCA, Ontario SPCA, SPA de Montréal) run hardship programs of varying scope. Some clinics quietly maintain a hardship fund for regular clients. None of these are large, but a $500 to $1,000 contribution can be the difference between a doable plan and an undoable one.

1. Prefer a low-rate line of credit or a real 0% intro credit card over a long-term BNPL installment. A Canadian unsecured line of credit at 7 to 10% APR is materially cheaper than a 12 or 24-month Fairstone plan if the 0% promo gets broken by a missed payment (which flips the remaining balance to roughly 30% APR). A credit card with a genuine 0% intro on purchases is similar, as long as you have a hard plan to clear it before the intro ends. Both put the financing under tools you already use to track money, instead of a third-party app that lives outside your bank dashboard.

1. If point-of-sale financing is the only option left, take the shortest term you can actually service. A 4-month Fairstone plan you can almost-comfortably absorb is much safer than a 24-month plan that gives you slack you don't have. The shorter the term, the smaller the window in which a missed payment can flip the promo into 30% APR retroactively. Read the term sheet specifically for the phrase "deferred interest" or "interest accrued from purchase date" before signing.

1. Take pet insurance seriously for next time. It doesn't help with this surgery (insurance won't pay for a condition that already exists), but the average Canadian indoor cat costs about $30 to $50 per month to insure with reasonable accident-and-illness coverage. After a $5,000 surprise, the calculus on whether $480 a year is worth it usually shifts.

One thing worth saying plainly because the rest of the post is mostly about the math. If you genuinely cannot afford the treatment and there is no path to making it work, talking to the vet about that openly is the right move. Vets have this conversation regularly. Most of them will help you find the path that's least bad, whether that's a scaled-back plan, a referral to a teaching hospital with subsidised rates (the University of Guelph's Ontario Veterinary College and the Université de Montréal's Faculté de médecine vétérinaire both take referrals), or, in the hardest cases, an honest discussion about quality-of-life decisions. The worst outcome is silently signing a Fairstone deferred-interest 24-month plan you can't service and ending up six months later with the cat already gone and 30% APR running on the balance. The financing screen at the counter doesn't show that path. The vet, asked directly, will.

The four questions worth asking before tapping "split"

1. Would I make this purchase today if the only option were paying in full? If yes, the split is fine. If no, the financing is doing the persuading, not the affordability.
2. Do I have the cash to cover the full balance right now, in an account I trust? If no, the split is a loan, not a liquidity tool, and the research above applies.
3. What's my actual recourse if a scheduled auto-debit fails? Card expiring before the last payment, bank flagging the transaction, account briefly below the debit amount. These are the failure modes the cheery checkout screen does not warn about. On a 12-month plan they multiply.
4. Which product am I signing for, a true 0% promo or a deferred-interest installment? They look identical at checkout. They are not the same product.

What happened over the four months

The four Fairstone debits cleared on schedule, $1,250 each, on days 30, 60, 90, and 120. The Desjardins emergency fund ran down from $5,000 to $0 over the same period. I captured about $21 of pre-tax interest yield I wouldn't have had if I'd paid upfront.

The operational cost was a small amount of attention. I set a recurring calendar reminder a few days before each debit to make sure the chequing balance was where it needed to be. After the second payment I called Desjardins to double-check the auto-debit description, because the merchant string on the statement was opaque enough that I wanted to confirm Fairstone was withdrawing the right amount on the right day. None of that was painful, but it was four separate "remember to think about this" moments over four months.

I never read the term sheet at the counter. Whether the plan was a genuine 0% installment or a deferred-interest promo that would retroactively charge me if I missed by a day was a question I carried for the full four months without an answer. The plan cleared cleanly at month 4, so it was genuinely 0% in this case. The right move would have been to read the contract at the counter instead of finding out at month 4. The risk I was actually running was small but unbounded.

For me, in that specific case, the math worked. $21 of yield, no missed payments, no surprise interest, and the cat is fine. If the term had been 24 months instead of 4, the unread term sheet would have been a meaningfully larger risk. If a single debit had failed on a Fairstone deferred-interest plan, the 0% promo could have flipped into about 30% APR on the remaining balance and the math would have inverted within weeks. The four conditions in the previous section did most of the work. The split was the cheap part.

Set aside a pet-emergency reserve before you need one

The reason I had a clean choice between paying in full and splitting at 0% is that the $5,000 was already sitting in Desjardins on the day of the surgery. If it hadn't been, the Fairstone plan wouldn't have been a small free liquidity win. It would have been a $5,000 loan against a budget that didn't have $5,000 of room. Same checkout screen, different product, very different math.

The single most useful thing you can do before you're standing at a vet clinic counter with a surprise estimate is to have set aside a dedicated pet-emergency reserve. The numbers I'd think about for one cat or one dog in Canada:

• $2,000 floor. Covers the common "something is wrong, we don't know what yet" workup: exam, bloodwork, imaging, a night of observation.
• $5,000 working level. Covers the typical small-to-mid emergency surgery (foreign-body removal, dental extractions, common soft-tissue procedures, the kind of thing my cat needed).
• $10,000 ceiling for a cat or small dog, $15,000 for a large dog. Covers the upper tail: complex surgery, post-op ICU, oncology workups. Above that you're into pet insurance territory.

These are reserves, not budgets. The point isn't to plan to spend $5,000 on the cat. The point is that when the estimate appears on the tablet at the front desk, the decision is "treat or not" rather than "treat or finance at 30% APR if the promo breaks". The reserve buys you the option to take the 0% Fairstone offer if it makes sense, and to ignore it cleanly if it doesn't.

A high-interest savings account is the right home for this. Desjardins's high-interest product, EQ Bank, Wealthsimple Cash, Tangerine's promo-rate periods, all work. The yield matters less than the separation from the rest of your money, so you don't have to mentally underwrite a vet bill out of your chequing balance under stress.

In Mozaic this is what the Goals feature is built for. You create a savings goal called something like "Pet emergency fund" with a target of $5,000, link the dedicated high-interest savings account to the goal, and Mozaic tracks the progress percentage against the target automatically as the linked account's balance moves. You don't update the number by hand. The progress bar reflects real money sitting in the account you chose. When the reserve is built, the goal sits at 100% and stays there as a quiet confirmation that the next surprise estimate at the vet clinic isn't a financing decision, it's a treatment decision.

Tracking the Fairstone plan alongside everything else (this is where Mozaic helps)

The trickiest practical thing about point-of-sale loans, more than the late fees, more than the credit-report exposure, is that they live outside the systems most people use to track money. A credit card balance shows up on your card statement. A car loan shows up on your bank app. A Fairstone or Affirm or Klarna plan shows up as an email confirmation, a series of scheduled debits in your calendar, and otherwise nothing. The debits hit chequing, so the loan isn't on any card statement. It isn't in your main bank's "loans" tab, because Fairstone holds the loan, not your bank. It's a liability that lives in a third-party app you opened once.

This is exactly the problem Mozaic is built for. Mozaic doesn't have a direct API connection to Fairstone, Affirm, Klarna, or Scratchpay. None of them expose data through Plaid or SnapTrade today, and I don't expect that to change quickly. What Mozaic does is connect to the chequing account the debits actually hit, classify the recurring Fairstone debit as a categorised transaction, and surface the four months of upcoming obligations alongside the rest of your financial picture.

In my case, after I took the plan, my Mozaic dashboard showed:

• The Desjardins emergency fund balance, declining $1,250 a month from $5,000 to $0.
• A "Fairstone vet plan" line item under liabilities, with $5,000 outstanding at the start and $0 at month 4.
• The four upcoming debits flagged on the calendar view, with the chequing balance projected against each.

None of that data lived in the Desjardins app on its own. None of it lived in the Fairstone email confirmation on its own. Putting it in one view is the part Mozaic does, and the part that made the four months feel like a managed plan rather than a series of separate "did the debit clear?" moments.

The same principle applies to tracking the FHSA against its lifetime cap and most registered accounts held at multiple institutions. The third party shows you a slice. You have to keep the full picture yourself, and the tooling exists to do it for you.

The bottom line. Who actually benefits.

Working backward through the funding stack:

• Merchants benefit unambiguously. Vet clinics, electronics retailers, and apparel brands pay 3 to 6% MDR for higher treatment-plan acceptance, conversion, and average ticket. Net positive.
• Point-of-sale lenders benefit unambiguously. They earn MDR on the 0% promo segment, interest on the longer-term segment (Fairstone's bread and butter), late fees and broken-promo interest from the stressed segment, and increasingly interchange and data revenue on top.
• Financially disciplined, higher-income buyers with the cash to cover the full balance benefit marginally. A free 4-month loan is real, even if the dollar value is small. In my case it was $21.
• The median user, per the converging research from CFPB, the FCA Woolard Review, and ASIC, is associated with measurably worse financial outcomes. More overdrafts, more delinquency on other credit, higher cumulative spending, and a non-trivial likelihood of missing essential payments to keep the plan current.

The product is structured so that the fourth group cross-subsidises the first three. The Fairstone option at the vet clinic counter was a real, small, free win for me because I had the dedicated emergency reserve, the disciplined auto-debit setup, and (this time) the luck of a 4-month term short enough that the unread term-sheet risk stayed bounded. For the buyer for whom the financing is what makes the $5,000 surgery feel possible in the first place, the research suggests the median outcome is worse than not splitting. Substantially worse if the plan turns out to be deferred interest rather than a true 0% promo.

A 0% split on a bill you'd have paid anyway, with the cash in hand and the reserve already built, is in expectation a small win. The same split against a budget that doesn't actually accommodate the underlying purchase is, per the regulators studying this market for the better part of a decade, a different product. The checkout flow does not distinguish between the two. The buyer has to.